Intention of Leaving the Service — Work Pressure for Pharmacist With Home Pharmaceutical Care
Citation(s)
Folkman S Personal control and stress and coping processes: a theoretical analysis. J Pers Soc Psychol. 1984 Apr;46(4):839-52.
Mak VS, March GJ, Clark A, Gilbert AL Why do Australian registered pharmacists leave the profession? a qualitative study. Int J Clin Pharm. 2013 Feb;35(1):129-37. doi: 10.1007/s11096-012-9720-5. Epub 2012 Oct 30.
Mosadeghrad AM, Ferlie E, Rosenberg D A study of relationship between job stress, quality of working life and turnover intention among hospital employees. Health Serv Manage Res. 2011 Nov;24(4):170-81. doi: 10.1258/hsmr.2011.011009.
Ramalho de Oliveira D, Brummel AR, Miller DB Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010 Apr;16(3):185-95.
Williams LJ, & Hazer, J T.. Antecedents and consequences of satisfaction and commitment in turnover models: A reanalysis using latent variable structural equation methods. . Journal of Applied Psychology. 1986;71:219-231.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
